{
    "clinical_study": {
        "@rank": "20178", 
        "arm_group": {
            "arm_group_label": "Lifestyle counseling", 
            "arm_group_type": "Experimental", 
            "description": "This is a single arm, quasi-experimental, pre- and post- test study design to test the feasibility and acceptability of a multiple risk factor, lifestyle intervention in patients receiving surgical treatment for lung cancer or those suspected of having lung cancer."
        }, 
        "brief_summary": {
            "textblock": "The objective of this proposal is to test the feasibility and acceptability of a lifestyle\n      risk reduction intervention for  patients with lung cancer receiving surgical treatment.\n      This study will provide the preliminary data needed to conduct a larger randomized\n      controlled trial  that tests an innovative, multidisciplinary intervention that has the\n      potential to transform the standard of care for patients receiving surgical treatment for\n      lung cancer."
        }, 
        "brief_title": "Healthy Directions After Lung Surgery Pilot", 
        "condition": "Carcinoma, Non Small Cell Lung", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Non-Small-Cell Lung"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patient Inclusion Criteria:\n\n          -  > 21 years of age\n\n          -  English speaking\n\n          -  MD approval to participate in study\n\n          -  Meets one of the inclusions below:\n\n          -  1. a histological diagnosis of NSCLC undergoing potentially curative treatment\n\n          -  2. OR those undergoing surgical procedures for lung cancer (includes patients\n             undergoing diagnostic testing or those presenting with lung nodules\n\n          -  3.OR patients who have had a surgical procedure for lung cancer within the last six\n             months.\n\n          -  May invite a buddy to join study with them defined as a friend, partner, adult child\n             or sibling\n\n        Buddy Inclusion Criteria:\n\n          -  \u2265 21 years of age,\n\n          -  English speaking, who is invited by the subject to join as a support person (e.g.,\n             friend, partner, adult child or sibling)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02135211", 
            "org_study_id": "12-150"
        }, 
        "intervention": {
            "arm_group_label": "Lifestyle counseling", 
            "intervention_name": "Lifestyle counseling", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "non-small cell lung cancer (NSCLC)", 
            "multiple risk factor", 
            "lifestyle intervention", 
            "health behavior", 
            "lifestyle risk reduction", 
            "health related quality of life"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Dana Farber Cancer Institute"
                }, 
                "investigator": {
                    "last_name": "Mary E. Cooley, PhD, RN, FAAN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham & Woman's Hospital"
                }, 
                "investigator": {
                    "last_name": "Raphael Bueno, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility and Acceptability of a Lifestyle Intervention for Patients Receiving Surgical Treatment for Lung Surgery", 
        "overall_contact": {
            "email": "manan_nayak@dfci.harvard.edu", 
            "last_name": "Manan Nayak, MA", 
            "phone": "617-632-5096"
        }, 
        "overall_official": {
            "affiliation": "Dana Farber Cancer Insitute", 
            "last_name": "Mary E. Cooley, PhD, RN, FAAN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The primary outcome measures to establish feasibility and acceptability of the intervention for this study are enrollment rates.", 
                "measure": "Feasibility and acceptability", 
                "safety_issue": "No", 
                "time_frame": "at end of study (4 months post intervention)"
            }, 
            {
                "description": "The primary outcome measures to establish feasibility and acceptability patient's use of intervention materials", 
                "measure": "Feasibility and acceptability", 
                "safety_issue": "No", 
                "time_frame": "at end of study (4 months post intervention)"
            }, 
            {
                "description": "The primary outcome measures to establish feasibility and acceptability of the  completion of self-monitoring", 
                "measure": "Feasibility and acceptability", 
                "safety_issue": "No", 
                "time_frame": "at end of study (4 months post intervention"
            }, 
            {
                "description": "The primary outcome measures to establish feasibility and acceptability of the intervention for this study completion of nurse-patient contacts.", 
                "measure": "Feasibility and acceptability", 
                "safety_issue": "No", 
                "time_frame": "at end of study (4 months post intervention)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02135211"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dana-Farber Cancer Institute", 
            "investigator_full_name": "Mary E. Cooley, Phd", 
            "investigator_title": "Nurse Scientist, PhD, RN, FAAN", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The secondary outcome measures of interest for this study are lifestyle risk reduction and Health Related-Quality of Life.", 
                "measure": "Interest for this study", 
                "safety_issue": "No", 
                "time_frame": "baseline, 1 month, & 4 month"
            }, 
            {
                "description": "The secondary outcome measures of interest for this study is an interview to evaluate the intervention will be conducted with the participant and the partner at the conclusion of the study.", 
                "measure": "Interest for this study", 
                "safety_issue": "No", 
                "time_frame": "baseline, 1 month, & 4 month"
            }
        ], 
        "source": "Dana-Farber Cancer Institute", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Brigham and Women's Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Massachusetts, Boston", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Dana-Farber Cancer Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}